The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 2, 2015, Pages 539-546

  Dehghani, Hossein ^a   Hashemi, Mehrdad ^a   Entezari, Maliheh ^a   Mohsenifar, Afshin ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Research and Development Department   (Iran)

Author keywords

Anticancer activity; MCF7 cells; MTT assay; Nanothymoquinone; Thymoquinone

Indexed keywords

CHITOSAN NANOPARTICLE; THYMOQUINONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; GEL; HUMAN; HUMAN CELL; IC50; MCF 7 CELL LINE; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84923067770     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nicholson DW. Caspase structure, proteolytic substrates,and function during apoptotic cell death. Cell Death Differ. (1999) 6: 1028-1042.
2. Mao TK, Van De Water J, Keen CL, Schmitz HH and Gershwin ME. Cocoa flavonols and procyanidins promote transforming growth factor-beta1 homeostasis in peripheral blood mononuclear cells. Exp. Biol. Med. (2003) 228: 93-99.
3. Cragg GM and Newman DJ. Plants as a source of anticancer agents. J. Ethnopharmacol. (2005) 100: 72-79.
4. Chen MS, Chen D and Dou QP. Inhibition of proteasome activity by various fruits and vegetables is associated with cancer cell death. In-vivo (2004) 1: 73-80.
5. Harborne JB and Williams CA. Anthocyanins and other favonoids. Nat. Prod. Rep. (2001) 18: 310-333.
6. Ghasemian A, Mehrabian S and Majd A. Peel extracts of two Iranian cultivars of Pomegranate(punica granatum) have antioxidant and antimutagenic activities. Pakistan J. Biol. Sci. (2006) 7: 1402-1405.
7. Traub ML, De Butte-Smith M, Zukin RS and Etgen AM. Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats. J. Neuroendocrinol. (2009) 21: 1038-1044.
8. Padhye S, Banerjee S, Ahmad A, Mohammad R and Sarkar FH. From here to eternity the secret of pharaohs: therapeutic potential of black cumin seeds and beyond. Cancer Ther. (2008) 6: 495-510.
9. Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH and Mohammad RM. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr. Cancer(2010) 62: 938-946.
10. Weinberg GL, Vade Boncouer T, Ramaraju GA, Garcia-Amaro MF and Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose response to bupivacaine induced asystole in rats. Anesthesiol. (1998) 88: 1071-1075.
11. Hoare T, Sivakumaran D, Stefanescu CF, Lawlor MW and Kohane DS. Nanogel scavengers for drugs: local anesthetic uptake by thermoresponsive nanogels. Acta Biomater. (2012) 8: 1450-1458.
12. Chen XG, Lee CM and Park HJ. O/W emulsification for the selfaggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. J. Agric. Food Chem. (2003) 51: 3135-3139.
13. Liu CG, Desai KG, Chen XG and Park HJ. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. J. Agric. Food Chem. (2005) 53: 437-441.
14. Badary OA, Nagi MN, al-Shabanah OA, al-Sawaf HA, al-Sohaibani MO and al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can. J. Physiol Pharmacol. (1997) 75: 1356-1361.
15. al-Shabanah OA, Badary OA, Nagi MN, al-Gharably NM, al-Rikabi AC and al-Bekairi AM. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J. Exp. Clin. Cancer Res. (1998) 17: 193-198.
16. Badary OA, Abdel-Naim AB, Abdel-Wahab MH and Hamada FM. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicol. (2000) 143: 219-226.
17. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N and Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs(2004) 15: 389-399.
18. Gali-Muhtasib H, Roessner A and Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources. Int. J. Biochem. Cell Biol. (2006) 38: 1249-1253.
19. Hochhauser D. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer. Anticancer Drugs(1997) 8: 903-910.
20. Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR and Aggarwal BB. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochem. Pharmacol. (2010) 79: 1640-1647
21. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL and Tithof PK. In-vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int. J. Oncol. (2003) 22: 107-113.
22. Motaghed M, Al-Hassan FM and Hamid SS. Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7. Pharmaco. Res. (2013) 5: 200-206.
23. Oh JK, Drumright R, Siegwart DJ and Matyjaszewski K. The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. (2008) 33: 448-477.
24. Oh JK, Lee DI and Park JM. Biopolymer- based microgels/ nanogels for drug delivery applications. Progress in Polymer Sci. (2009) 34: 1261-1282.
25. Gupta V, Aseh A, Rios CN, Aggarwal BB and Mathur AB. Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int.J. Nanomed. (2009) 4: 115-122.
26. Aggarwal BB, Gupta SC and Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br. J. Pharmacol. (2013) 169: 1672-1692.
27. Hashemi M. The study of pentoxifylline drug effects on renal apoptosis and BCL-2 gene expression changes following ischemic reperfusion injury in rat. Iran. J. Pharm. Res. (2014) 13: 181-189.
28. Khazaei Koohpar Z, Hashemi M, Mahdian R and Parivar K. The effect of pentoxifylline on bcl-2 gene expression changes in hippocampus after long-term use of ecstasy in wistar rats. Iran. J. Pharm. Res. (2013) 12: 521-527.